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ABSTRACT 
PROBING FOR CONFORMATIONAL CHANGES IN THE REPAIR ENZYME MFD 
USING MUTANT PROTEIN CONSTRUCTS 
MAY 2008 
MARY HUNNEWELL, B.S. and B.A., UNIVERSITY OF MASSACHUSETTS 
AMHERST 
M.A., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor KarstenTheis 
  
DNA repair is essential for survival, as damage to the genome can interrupt the 
precarious balance of cell functions, causing further mutations and possibly leading to 
cancer.  The bacterial transcription repair coupling factor, Mfd, is capable of recognizing 
a stalled RNA polymerase at a site of DNA damage.  The Mfd works both to remove the 
RNA polymerase through its motor function (utilizing the energy of ATP to translocate 
along DNA), and to recruit the DNA repair complex UvrA/B/C.  To study 
conformational changes in the protein, we are creating multiple mutants of the full length 
Mfd protein.  My approach is to use a cleavable mutant of full-length Mfd as a template 
for further mutations.  This will allow us to probe for conformational changes by 
changing interactions at the interface of the two halves of Mfd, and then using the ability 
to cut with TEV protease as a sensor to identify and characterize the open state of the 
protein.  By introducing this TEV protease cut site at residue 450 in the protein linker 
region between the N (amino-) and C (carboxy-) terminal domains, we can then assess 
the conformational changes Mfd must undergo to obtain activity.  We can study the effect 
vi 
of further mutations on the full length and cut versions of the protein.  Another approach 
attempted in this study involves using cysteine modification of the full length Mfd 
protein as a sensor for these conformational changes.  Mfd acts as a model system for 
studying the DNA repair mechanisms found in humans, and the elucidation of functional 
and conformational changes in Mfd contributes to studying disease phenotypes resulting 
from aberrant transcription coupled repair.   
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CHAPTER I 
INTRODUCTION 
General Background 
Living organisms have a complex network of devices for modulating their cellular state.  
The organism grows and develops in a highly regulated way, maintaining tight control over all 
internal mechanisms of each of its cells.  This includes modulating the balance between cell cycle 
control, cell maintenance and apoptosis (programmed cell death).  This balance is based on the 
ability of the organism to repair damage that occurs in the DNA.  DNA lesions in the gene 
sequence may interfere with replication or transcription, resulting in the loss of key 
transcriptional products that the cell needs to function properly and survive (Figure 1.1).   
 
 
 
 
 
 
 
 
 
 
 
 
Conditions like UV irradiation or exposure to chemicals from tobacco smoke can cause 
these disruptive lesions in the DNA (Figure 1.2).  DNA lesions are extremely detrimental to 
living organisms, in some cases preventing transcription of whatever gene is encoded by the 
affected sequence.  In these cases, the RNA polymerase moving along an actively transcribing 
DNA Damage 
 
 
DNA Repair 
 
Mutations 
Replication Errors 
 Persistent DNA Damage 
 
Genomic Instability 
Cancer 
Cell death 
Aging 
Replication 
Figure 1.1: Implications of DNA Damage.  DNA damage can cause either cancer 
phenotypes or cell death and aging by contributing to replication errors, genomic 
instability, persistent DNA damage, as well as many different types of mutations.  
DNA repair at sites of damage is necessary in rescuing the information encoded by 
genes and necessary for normal cell function.  The selective repair of genes that are 
being actively used is useful in preventing cell death and aging that result from the 
inability of the cell to deal with damage.  It can also prevent cancer phenotypes 
resulting in unchecked mutations that do not lead to cell death but instead cause the 
cell to proliferate or evade cell death. 
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gene stops when the damage is about to enter the active site, and the polymerase becomes stuck in 
a stalled position.  The stalled polymerase further prevents transcription of essential genes and 
prevents other DNA-dependent processes like replication and repair, which often leads to cell 
death.  Other times, the cell can survive without repairing DNA damage, but can proliferate out of 
control due to unchecked mutations.   
 
 
 
 
 
 
Nucleotide Excision Repair 
The process of nucleotide excision repair is found in living organisms as an enzymatic 
pathway of repairing damaged regions of the gene sequence.  Global repair refers to the repair of 
DNA damage that is directly recognizable and accessible to nucleotide excision repair proteins.  
In bacteria, recognition of damage is through the repair proteins UvrA and UvrB, which then 
Figure 1.2: Various types of DNA damage that lead to the action of repair 
mechanisms.  The above shows various forms of nucleotide base mutation.  
Deaminated bases occur spontaneously and generate substantial lesions in 
DNA.  Thymine dimers result from exposure of DNA to UV light.  Abasic sites 
are frequent forms of damage that often occur as a result of chemical or 
radiation damage.  8oxoG is an example of a modified nucleotide base that is 
caused by the effect of radical oxygen species (ROS) on DNA. 
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recruit other enzymes to repair the damage.  When the damage cannot be directly repaired due to 
the stalled polymerase blocking the damage, transcription-coupled repair is utilized.  This 
involves the presence of a coupling factor, which is needed as a mediator to recognize DNA 
damage, remove RNA polymerase, and recruit the UvrABC complex to the site of damage for 
excision repair.   
 
RNA polymerase stalled at DNA 
damage is recognized by Mfd
UvrB
pre-incision complex 
(UvrB “padlock” bound 
to damaged DNA) 
RNA,
RNAP Mfd UvrA2
UvrA2 UvrB
RNA Pol
RNA 3’OH
Mfd
C
N
COUPLING
 
 
 
 
 
 
Mutation Frequency Decline 
Mfd (Mutation frequency decline, as named for the activity which led to its discovery) 
refers to the bacterial transcription-repair coupling factor (TRCF).  Mfd is a 130 kDa protein, 
made up of 1148 amino acid residues and therefore, 3444 base pair nucleotides.  Mfd is an active 
enzymatic mediator of transcription and repair processes in bacterial species.  Though present 
only in bacteria, Mfd has functional homologues in both mammals and yeast.  The enzymes 
critical for transcription-coupled repair in mammals are Cockayne Syndrome A (CSA) and 
Cockayne Syndrome B (CSB), while the functional homologue in yeast is Rad26.  Yeast shows 
decreased ability to carry out repair processes when deprived of Rad26, but is capable of 
Figure 1.3: Mfd in transcription coupled repair.  The independent 
mechanisms of transcription coupled repair (TCR) and global nucleotide 
excision repair converge for the processes of excision and repair.  In this 
figure, the ‘coupling’ box of transcription coupled repair mediated by the Mfd 
protein represents the unknown mechanism of binding of each of the 
molecules involved in the process.  The elucidation of these interactions in the 
‘Coupling’ box is useful in studying the process as a whole. 
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repairing actively transcribed genes without it.  It seems that the high efficiency of the global 
repair process in yeast makes up for the disruption of transcription coupled repair (TCR) 
mechanism.  In humans, who are more dependent on TCR, many diseases arise from mutations in 
these coupling-type repair proteins.  For example, Cockayne syndrome results when there is a 
loss of repair function by CSA or CSB (van Gool et al 1997).   
Mfd, the bacterial E. coli protein, serves as a model system for counterpart helicase and 
translocase activity in humans.  Helicases are often critical to the ability of organisms to sense 
DNA damage and remodel the gene sequence during repair processes, as they are constantly 
interacting with DNA, packaging/unwinding for altering levels of transcriptional activity 
(Friedberg et al., 1995).  Many human helicase enzymes, when damaged or mutated, can lead to 
diseases and are often implicated in cancer development/formation.  Mfd as well as its eukaryotic 
counterparts Rad26 and CSA/CSB act very specifically to repair the template strand of genes that 
are actively being transcribed, acting preferentially on these critical genes rather than on non-
transcribed gene regions (for which repair is less critical).  Mutagens from the environment as 
well as within the cell can cause DNA lesions of transcribing genes.  The noncoding strand’s rate 
of repair is similar to the repair rate of untranscribed genes, showing that genes have to be 
actively transcribed for TCR to work (Svejstup, 2002).   
 Each of the TRCFs present in these various systems contain helicase-like motifs that 
provide for translocation along DNA and, presumably, subsequent RNA polymerase movement.  
In order to displace RNA polymerase and free up the damage for repair, the TRCF must 
counteract a tight interaction between the RNAP/DNA complex (Selby and Sancar 2003).  A 
major goal in the Theis lab is to study the molecular details of this process in our model 
organism, Escherichia coli.  
The fundamental mechanism of action is as follows (Fig. 1.3).  Mfd recognizes a stalled 
polymerase at a site of DNA damage.  Mfd functions as an ATP-dependent motor protein to 
catalyze the dissociation of the polymerase from the damaged template strand of DNA.  Mfd then 
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binds to the UvrA repair protein, and through this protein recruits the entire nucleotide excision 
repair complex to the damaged site, acting as a transcription repair coupling factor.  Mfd has also 
been shown to function in a slightly different way when recognizing a stalled polymerase along a 
strand of DNA that does not have a substantially damaged region.  In this case, instead of 
removing the polymerase and recruiting the repair proteins, Mfd can rescue the RNAP elongation 
complex by pushing the polymerase so that the active site is again on the 3’ end of transcript 
(Parks et al 2002). 
This suggests that in the latter case, Mfd acts through its ATPase activity to pull the DNA 
from under the transcribing RNA polymerase, and therefore promote continuing transcription.  
However, the involvement of Mfd in repair functions is that it works to push the RNAP off DNA, 
leaving the DNA ready for repair proteins to repair the damage (Svejstrup 2002).  In either role, 
Mfd must use its motor ability to displace the RNA polymerase that has stalled along the DNA.   
The crystal structure of Mfd consists of 7 distinct domains (Figure 1.4A, Deaconescu et 
al 2006).  The N-terminal fragment (residues 1-450, domains 1-3) is responsible for recruitment 
of the repair complex. The crystal structure of the UvrA binding N-terminal part shows a fold that 
resembles domains 1a, 1b and 2 of the repair protein UvrB, with the highest level of similarity to 
the UvrA binding domain 2 of UvrB.  The C-terminal part (residues 478-1148, domains 4-7) of 
Mfd contains helicasesuperfamily II motifs (including motifs shown to be responsible for ATP 
binding in other members of the family) (Singleton and Wigley, 2002). Deletion studies have 
shown that these domains are required for the motor activity of the Mfd protein in removing the 
polymerase from the damaged strand (Selby and Sancar 2005). Between the N and C termini is a 
short linker region (residues 450-478).  Domain 4 of the C-terminus is considered to contain an 
RNAP-interacting domain, capable of binding to the polymerase.  Domains 5 and 6 of the 
Carboxy-terminus contain the ATP binding regions of the protein. 
The available crystal structure of full-length Mfd (Deaconescu et al 2006) is that of the 
apo-enzyme, i.e. in the absence of binding partners such as damaged DNA, polymerase, and ATP.  
6 
Mfd’s binding sites for ATP are occluded in the apo-form, in the movement of the helicase 
domains 5 and 6 appear to be hindered by interactions with the N-terminal domains 1 and 3. 
Furthermore, the C-terminal domain 7 appears to interfere with the binding of UvrA to its binding 
site located on the N-terminal part of the protein (Figure 1.4B). Deaconescu et al (2006) have 
proposed that in order to be functional, the apo-Mfd structure has to undergo large 
conformational changes.  Deletion of domain 7 was recently shown to be compatible with motor 
activity (indeed, this deletion enhances both ATPase and RNAP removal activity of Mfd), but the 
effects on UvrA binding have not been tested (Smith and Savery 2007). In this work, the 
mechanism of Mfd activation is investigated. 
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A. 
 
 
 
 
 
 
B. C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Structure of Mfd. The layout of the gene for Mfd is shown in part A 
with the major binding interactions summarized directly below each domain.  
Important areas to note are the UvrA binding of domain 2, the domain 2 binding of 
domain 7, and the ATP binding of domain 5.  Part B above shows the protein 
structure of Mfd in its apo-form, independent of damaged DNA, polymerase and other 
cofactors such as ATP.  The cartoon model is shown in C, with the linker shown in 
red, the N terminal fragment in yellow, and the C terminal fragment in blue.  In the 
closed form of Mfd, domain 7 blocks UvrA interaction with domain 2.  MfdN 
(domains 1-3) and MfdC (domains 4-7) form a compact structure as shown in B and C, 
connected directly by a small linker shown in green in B and red in C.  Domain 4 is 
largely responsible for interaction with the RNA polymerase, and domains 5 and 6 
bind and hydrolyze ATP for motor functioning.   
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CHAPTER II 
EXPERIMENTAL DESIGN 
Open Conformation Hypothesis 
From studies of Mfd in the apo-form (isolated from transcription machinery and other 
protein interactions), it has been argued that Mfd is incapable of performing its two distinct 
functions while in this form (Deaconescu et al 2006, Savery 2007). Structural and biophysical 
studies conducted in the Theis laboratory suggest that the N-terminal part of Mfd fold 
independently, is highly stable and is a rigid clamp bound to the motor domains of Mfd in the 
full-length enzyme in its apo-form (Murphy and Theis, unpublished). Our hypothesis is that Mfd 
undergoes a structural alteration, which exposes the necessary binding sites to UvrA and allows 
movement of the motor domains as well as the binding and hydrolysis of ATP.This large-scale 
conformation change would disrupt all interdomain contacts between MfdN (domains 1 – 3) and 
MfdC (domains 4 – 7) that inhibit these two functions, effectively activating the Mfd protein.  In 
the envisioned open form, both recruitment of UvrA for repair and binding and hydrolysis of ATP 
for motor activity would be simultaneously activated.  The cartoons in Figure 2.1 represent the 
proposed open conformation hypothesis.  
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A. 
 
 
 
 
 B. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Open conformation hypothesis.  The apo-Mfd structure, 
shown in part A on the left and in part B on the top, is incapable of binding 
to UvrA for the recruiting function of Mfd.  It also cannot hydrolyze ATP 
efficiently for the motor activity of the protein.  Therefore, the hypothesis is 
that in order to be functional as a coupling factor, capable of both binding 
ATP and UvrA, the Mfd protein must undergo conformational changes in 
order to make these binding sites accessible.  Therefore, the Mfd protein 
opens up into the open conformation shown on the right in A and bottom in 
B, in which it is then capable of binding ATP and UvrA.  Also, in Part B, 
the active open form of Mfd is shown to interact with both DNA and RNA 
polymerase in addition to the ATP. 
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In order to test the hypothesis of an open conformation of Mfd, we proposed introducing 
a cut site for the TEV (Tobacco Etch Virus) protease into the linker region of the gene.  Another 
member of the lab, Kenneth Ralto, created the cleavable protein by inserting 6 amino acids at 
position 450 in the linker.  The recognition site was as follows, with the recognition sequence for 
TEV protease in red, and the required inserted amino acid sequence underlined:  aa 446-
ESDLLENLYFQGERVA- 455.  This site, in the design process, was assumed to be inaccessible 
in apo-Mfd.  We hypothesize that it would be fully cleavable only when Mfd opened up, because 
the sequence was inserted at amino acid 450, at the beginning of the linker connecting domains 
three and four of Mfd.  Therefore, we assumed that it could be useful as a sensor for the open 
conformation of Mfd.  Because the buried cut site in closed Mfd was not directly accessible to the 
TEV protease because of steric constraints seen based on the apo-Mfd crystal structure, the faster 
the protein was cut, the more “open” the Mfd would be assumed to be.  This would allow us to 
perform kinetic studies of proteolysis of Mfd under various conditions.  In addition, the 
engineered cut site would allow us to directly study and compare full length and cleaved versions 
of Mfd.   
  
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutants of cleavable Mfd with weakened MfdN:MfdC interactions 
In my project, I am studying cleavable Mfd in the two ways outlined above.  My 
approach was to make multiple different mutants of the (already mutated) cleavable form of Mfd 
designed to weaken MfdN: MfdC interactions.  I planned to express and purify the various mutant 
proteins, and study the effect of mutations that are designed to potentially destabilize the interface 
between Mfd-N and Mfd-C.  We expected to see increased proteolysis if our mutant protein was 
destabilized because the destabilization would increase the ability of the protease to cut at 
L450 L450 
Figure 2.2: Location of the engineered 450TEV cut site.  The structures 
above show Mfd with the C terminus in blue and the N terminus in yellow.  
On the top left is the surface representation of the protein halves, connected 
by the red linker region.  On the top right is the same structure with the N-
terminus made transparent so that the engineered recognition site is visible by 
the 6 amino acids inserted shown in green.  The site is buried in the interface, 
and the TEV protease crystal structure is shown to the left to emphasize the 
obstructed access of the protease for the cut site in Mfd.   
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position 450.  Also, with a destabilized interface, our open conformation hypothesis predicts that 
there would be increased ATP hydrolysis, as the protein would be closer to the open, active state 
of a fully functional (or maybe even hyperactived) Mfd protein.   
Table 1 shows the expected results of my own and future experiments in the lab 
concerning the mutants I created.  The goal is to study the effect of the mutations on the interface 
of Mfd, and also to create mutants in an attempt to express and purify a hyperactive mutant that is 
constantly in the “open” conformation.  In other words, this hyperactive mutant would have a 
destabilized interface between the N and C termini of Mfd.  Forming an always-open mutant 
would allow us to perhaps form active Mfd complexes with interaction partners of Mfd, and these 
efforts could lead to crystallization of an active form of Mfd.  Characterizing the open form of 
Mfd through crystallization and biochemical studies is critical in determining how Mfd functions, 
such as how it binds DNA and removes the polymerase from lesions on damaged DNA.   
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MfdC-
MfdN 
Interactions 
ATPase 
Activity 
Linker 
Proteolysis Stability 
UvrA 
Interactions Toxicity 
Normal Low Slow 1 broad transition Weak Low 
Weak High (=Mfd C?) Fast 
2 transitions 
(for N and C 
acting 
separately) 
Strong High 
Mfd-C High (>20 fold normal) n.a. 1 transition n.a. High 
 
 
 
 
 
 
 
 
 
 
 
Designing interface-disrupting mutants 
When designing mutants, we tried to target areas of Mfd that are shown to contribute to 
the interface interactions between MfdN and MfdC.  In our analysis, we identified three different 
contact points between the two halves.  Domain 7 and 2 have clear interactions, as well as 
domains 1 to 6 and domain 3 to 5.  A scheme of these interactions is shown in Figure 2.3.     
 
Table 1:  Expected mutant properties.  The table shows how mutant Mfd proteins are 
expected to behave when they exhibit normal or weak MfdC-MfdN interactions.  A 
mutant with normal interactions would behave very similarly to wildtype Mfd.  They 
would have low ATPase activity and slow linker proteolysis due to the large amount of 
closed-form Mfd.  If a mutant destabilizes the interface, we would expect weak 
interactions between the two termini, as the protein is being forced into this open, active 
form.  With weak interactions, the protein would exhibit high ATPase activity, probably 
comparable to the activity of separately expressed Mfd-C (which is approximately 20-
fold normal).  It would also have increased proteolysis compared to the normal, as well as 
two separate transitions in circular dichroism experiments performed for stability 
analysis.  (The two halves of Mfd, if destabilized, would be acting effectively as two 
separate proteins joined together just by the linker region).  UvrA interactions would be 
strong compared to normal, as nothing would be blocking the domain 2 UvrA binding 
site when the protein interface is opened.  We would also expect any hyperactivated, 
open protein with weak MfdC-MfdN interactions to be highly toxic to the cells.   
14 
 
 
 
 
 
R804D mutation 
 The first mutant I worked on was the R804D mutant of the already cleavable Mfd, which 
changed a positively charged arginine in domain 6 of the protein to a negatively charged aspartate 
residue.  Domain 6, as shown in Figure 2.3, contacts domain 1 of Mfd-N.  Therefore, if we 
reverse the charge of a residue that is involved in these interactions, we can eliminate a salt bridge 
at that position.  This could allow us to create a hyperactive mutant that is effectively pushed 
apart by charge repulsion instead of being tightly bound together by charge attractions.  Figure 
2.4 shows the positively charged patch of residues on Mfd-C and where they interact with 
negatively charged residues on Mfd-N.  These residues are all mutation targets, but the one I 
focused on was 804, circled in red in Figure 2.4.   
Figure 2.3: Interaction patches between Mfd-N and Mfd-C. The ribbon 
model shows Mfd-N, with residues of the interface marked with gray spheres. 
Arrows indicate where these residues of domain 1,2, and 3 interact with Mfd-
C.  Mfd-C is shown in the inset as space-filling atomic model, and the black 
lines outline the three different contact points.  
15 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 2.4:  Salt bridge interactions.Mfd-C is shown on the left and Mfd-N on 
the right, with the interface interactions in black.  Note the presence of positively 
charged residues (in blue) on Mfd-C interacting through salt bridges with 
negatively charged residues (in red) on Mfd-N.  The protein in this figure is 
being opened up like a book.  Key residues that are targets for mutation are 
shown, with the R804 circled. 
Figure 2.5:  Cartoon of 804D location and effects on 
conformation.  The hypothesis is that upon switching the charge 
of the residue normally involved in a salt bridge, the N and C-
terminal parts of Mfd will be pushed apart into a more open 
conformation.   
16 
A.  
 
B.  
 
 
 
 
 
 
 
Figure 2.6:  Bottom view of Mfd. (A) This view is from the bottom of Mfd looking 
up (compared to Fig. 2.2).  Mfd-C is again in blue, with domains 5 and 6 in different 
shades, and the position of ATP binding and hydrolysis indicated.  Also shown is the 
hypothesized DNA-binding region.  The position of R804D is indicated, as well as 
various other important residues and potential mutation targets.  Important to note is 
the separate location of the ATP binding site from 804D, and the position of 804D at 
the interface between domain 6 in blue and domain 1 in yellow.  (B) An enlarged 
view of the linker connecting N (yellow) to C (blue).  The arrow indicates the region 
where the 6 amino acid insertion was made to introduce the TEV recognition site 
into the protein.  Note that from this bottom view, the region does not seem quite so 
buried or inaccessible to the protease (discussed further in conclusions session).   
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Delta 7 mutation 
This mutant was designed based upon work done by the Savery lab (Smith et al 2007).  
Their lab formed a construct of Mfd without domain seven (Mfd (1-997)).  Our mutation 
(∆7,450tevMfd) is a deletion of domain seven (same residues) from the cleavable 450tev 
construct of Mfd (deleting residues 1003-1154 from the 450tev construct).  The Savery lab’s 
previous work on the ∆7 mutant showed that while wildtypeMfd was incapable of removing a 
triplex strand from dsDNA in isolation, the ∆7 mutant could efficiently remove the strand (and 
therefore translocate along DNA) even in isolation.  This result indicated that domain 7 may 
inhibit the translocation activity of Mfd.  The Savery lab also showed that ∆7 Mfd had more than 
5 fold ATPase activity than the wildtypeMfd (Smith et al 2007).  These results indicate that ∆7 
Mfd is more similar to Mfd-C than to wildtypeMfd, in its ATPase activity.   
 Our cleavable version of ∆7 Mfd is important to study because we can see the effect of 
the mutation on the full length cleavable protein, comparing with published data.  Also, with the 
ability to cut the protein into 2 pieces, we can monitor if the effects seen in the full length protein 
are due to a disruption in C-N interactions or due to some other change in the protein.  Figure 2.7 
shows a view of the apo-structure of Mfd highlighting where domain 7 is thought to occlude the 
UvrA binding site (domain 2).  Domain 7 is deleted in the ∆7 mutant protein.   
 
Figure 2.7: Crystal structure 
showing placement of domain 7.  
This structure of Mfd indicates the 
UvrA binding site of domain 2 being 
occluded by the position of domain 7 
in the apo-closed form.  By deleting 
domain 7, we assume that this will 
overcome the autoinhibition of Mfd 
for its binding to UvrA.   
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My intentions were to create the ∆7 cleavable form of Mfd, purify the protein, and use it 
in experiments of ATPase function and rates of proteolysis as well as stability/functionality tests 
and the ability of the mutant to bind UvrA.   
 
Pegylation Project 
 A secondary project I pursued was to study conformational changes in Mfd through the 
use of a modification reagent.  I used a cross linking reagent that reacts with cysteine residues that 
are in accessible positions on a protein.  PEGmal (a compound formed by linking maleimide to a 
linear chain of polyethylene glycol) is a 5 kD molecule that is capable of crosslinking to cysteine 
residues through its maleimide moiety.  By reacting protein with this reagent, we can see what 
regions of Mfd are accessible for modification in different states.  In this way, the modification is 
similar to the proteolysis experiments in that we may be able to use it as a sensor for the open 
conformation of the protein by assessing the extent of PEGylation over time.  The 5 kilodalton 
modification should be visible on SDS-PAGE gels.  This method of sensing open-ness leads to 
even more mutant protein possibilities.  My approach was to start making mutants and see if we 
could visualize changes in PEGylation due to these modifications on an SDS-PAGE gel.  
In closed Mfd, we predicted based on the structure of apo-Mfd that only one cysteine on 
Mfd-N (of the three cysteines) is accessible, namely Cys27.  In order to improve readouts on the 
gels, we decided to see if we could remove this cysteine by mutating it to a leucine (Cys27Leu 
mutant).  In addition, we intended to make mutants of the cleavable Mfd that had cysteine 
residues introduced at a place on the interface of the protein (Leu401Cys) that is inaccessible to 
PEGylation in the apo-Mfd structure, and are predicting to become accessible when Mfd switches 
to an open and active conformation.  If the sites are designed correctly, we could see increased 
PEGylation when we cut the protein in half. If this positive control gives a good readout, we 
could use the ability to modify with PEGmal as a sensor for the open state of Mfd depending on 
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possible triggers of conformational change such as ATP, DNA, UvrA or stalled RNAP.  This 
sensor would be a powerful tool in studying the activation process.   
 
 
Figure 2.8: PEG-modification as a sensor for open 
conformation.PEGylation can be used in this assay as a sensor by comparing 
a control sample (that is fully digested and then modified) with the 
experimental sample (reacted with PEG first and then digested and isolated).  
If Mfd is closed when the assay is performed, you would expect little 
PEGylation at interface sites.  However, if a mutant is made that pushes the 
halves apart and makes a site that was buried now accessible, you would 
expect increased PEGylation early on, similar to that seen in the control 
(which represents the completely open state of the protein).  Gel readouts 
show what is expected for a quickly modified control sample (right) as 
compared to a slowly modified experimental sample (left).  This 
experimental sample would be closer to a closed form Mfd that has sites in 
the interface PEGylated slowly due to inaccessibility. 
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CHAPTER III 
MATERIALS AND METHODS 
Materials 
Cell Strains 
Escherichia coli strains DH5α and BL21(DE3) pLysS were taken from the  Theis lab 
collection and stored as glycerol stocks at -80 °.  DH5α was used as the cloning strain of cells for 
the mutant proteins created, and BL21(DE3) pLysS was used as the expression strain for each of 
the mutants.  The expression strain contains a second plasmid, pLysS, which confers 
chloramphenicol resistance and is used to maintain tight control of protein expression in T7 RNA 
Polymerase-based systems.  The pLysS expression plasmid expresses T7 lysozyme protein, 
which binds to T7 RNA polymerase and inhibits its transcription before induction.  When 
induction by IPTG occurs, T7 RNA polymerase is overproduced and this overcomes the 
inhibition by the T7 lysozyme coded for by pLysS, allowing pET23d to be transcribed and 
produce Mfd variants. 
 
Reagents 
Bacteriological media was made in the lab according to general lab recipes.  LB was 
prepared combining 10g Tryptone, 5 g Yeast Extract, and 10g NaCl in 1 liter deionized water.  
Plates were identical except for the addition of 15g per liter of Agar.  All media was autoclaved 
before use.  Antiobiotic was added as necessary after autoclaving.  10% SDS gels were used for 
protein experiments.  The gels were run at 100 volts through the stacking gel, and then were 
switched to 150 volts through the resolving gel.  Bands were visualized using a Gel Dock 
instrument after staining with Coomassie or GelCode Blue (Pierce) dye and then 
washing/destaining with ultra-pure, deionized water.  1% Agarose gels were used for DNA with 
ethidium bromide staining.   
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Mfd expression construct 
For the experiments, we used the expression plasmid pET23d (Novagen), with the full 
lengthwildtypeMfd gene inserted into the multiple cloning site (utilizing HindIII and NcoI 
restriction enzyme cut sites)(KarstenTheis, personal communication).  Mutants were then made 
of this full length wildtypeMfd construct, or of 450tev-Mfd (Kenneth Ralto, unpublished) 
containing the cleavable linker mutant described in Chapter 2 and Fig. 2.2.  pET23d is 3663 base 
pairs without the Mfd gene inserted.  Important features of this plasmid vector are the T7 
promoter and coding sequence, ampicillin resistance to provide for selection, a multiple cloning 
site region used for incorporating the Mfd gene sequence, and a C terminal His-Tag coding 
sequence.  Mutant constructs were based on this full length Mfd-containing plasmid, and were 
created using various mutagenesis techniques discussed.   
 
Methods 
 
Creating Mfd Mutants 
Quikchange Mutagenesis 
 The Quikchange Site-Directed Mutagenesis Kit (Stratagene) was used to form R804D, 
L401C, and C27L mutants.  Stratagene’sQuikchange mutagenesis allows mutations to be 
introduced at particular sites along a double stranded plasmid sequence.  Figure 3.1 shows the 
general procedure used for introducing mutations using this strategy. 
 
 
 Primers designed for Quikchange were checked by the Quikchange primer evaluator 
(<http://tim.saraogtim.com/molbio/qctemp.php
mutants that I created are shown in the chart below, with the location of the new amino acid 
shown in lowercase letters. 
R804D 5’ GTCCGGGAGGCGATCCTGgatGAAATTTTGCGCGGAGG 3’ 
L401C 5’ CCGTGAAGCGCTGGGTGAAtgcCTCGCACGAATTAAAATTGC 3’
C27L 5’ GTTAACCGGCGCAGCCttgGCAACGCTGGTAGCG 3’
 
Standard Quikchange protocol was used for reagent mixes for all mutants.  Pfu
(Stratagene) was used for the extension reactions, and the parameters were as follows: 1 cycle for 
2 min at 95 °C, then 18 cycles of 30 sec at 95 
kb plasmid for Pfu Turbo).  For all mutan
to introduce the mutations into the cleavable form of Mfd. 
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>).  Sense primers for the three different point 
 
 
°C, 1 min at 55 °C, and 9 min at 68 
ts, the plasmid pet23d 450tev-Mfd was used as template 
 
Figure 3.1: Quikchange 
mutagenesis scheme.  This 
figure shows a step-by-step 
protocol for Quikchange
mutagenesis, beginning with 
primers introducing the 
mutation in double stranded 
plasmid DNA.  This is 
followed by Dpn1 digestion 
and transformation into E. 
coli cells. 
Source: 
http://www.uhmc.sunysb.edu
/bioscience/img/strat1.gif
 
 
Turbo polymerase 
°C (>1 min per 
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Before transformation by electroporation, the products from the Quikchange extension 
reactions were purified through the QIAGEN PCR purification protocol, using the QIAquick 
PCR Purification Kit.  Transformation of the mutant plasmid was performed by way of 
electroporation.  This involved adding 5µL of each sample into 50µL DH5αelectrocompetentE. 
Coli cells.  The contents were transferred to electroporation cells, and the electroporator was set 
to 1610 volts.  After applying the voltage, I immediately added 1 ml of SOC or LB media to the 
sample, and incubated the samples for 1 hour at 37°C.  Then, 150-300 µL of each sample was 
plated onto LB plates containing ampicillin. 
 
Inverse PCR deletion  
 Inverse PCR was used to form the ∆7 cleavable Mfd mutant, with amino acids 1003-1154 
deleted from pET23d 450tev-Mfd (used as template plasmid).  Briefly, phosphorylated primers 
were used to amplify the plasmid leaving out the region of deletion (see Figure 3.2 below), he 
product was self-ligated and transformed into the E. coli cloning strain for further 
characterization.   
 
 
    
 
Primer 1 
Primer 2 
∆7 Deletion 
Figure 3.2:  Inverse PCR 
scheme.  Primers are made so 
that they amplify the region 
excluding the area of deletion, 
and must be phosphorylated.  
Linear PCR products result 
from the reaction, which then 
must be ligated to form a 
double stranded plasmid with 
the desired deletion.   
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I followed normal PCR primer design parameters, except they were ordered 
phosphorylated.  The sequences of the primers were as follows: 
Primer 1 5’   GAG ATC TTC CAG CGA CGG CTC G    3’  (22mer) 
Primer 2 5’   AAG CTT GCG GCC GCA CTC GAG       3’  (21mer) 
 
Cycling Parameters used were as follows: 1 cycle of 30 sec at 98 °C, then 30 cycles of 10 sec at 
98 °C, 30 seconds at 68 °C, and 4 min at 72 °C.  Phusion Polymerase (New England Biolabs) was 
used with the recommended PCR mixtures, except that GC instead of the recommended HF 
Phusion buffer was used in the PCR reaction.  Ligation was performed by mixing 10 µl sample 
with 10 µl Quick 2X ligation buffer and 1 µl T4 ligase and incubating the mixture at room 
temperature for 15 minutes, then transforming into NEB Turbo competent cells.  The chemical 
transformation was performed by adding 5 µl ligation product to 50 µl competent cells.  The 
mixture was placed on ice for 30 min, flicking every 10 minutes to mix.  Heat shock was at 42 C 
for 30 sec in a water bath, after which the mixture was placed on ice for 2 minutes.  250 µl of LB 
was added and incubated at 37C for 1 hour, shaking at ~200 rpm.  100 µl sample was then plated 
onto LB-amp plates.   
 
Minipreps and Identification of Mutant Plasmids 
Overnight cultures of resulting colonies were done followed by minipreps performed 
according to the QIAprepMiniprep Kit from QIAGEN.  Final products were eluted with 80 µl 
RNA-free water.  The candidate ∆7 constructs were analyzed by single and double digestions as 
described and then sent in for sequencing to verify identity.  Single and double digests were 
performed as follows: 
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Single and Double Digest of samples: 
 
Single (HindIII)                            Single (Nde1) 
2 µl Ne2 buffer                             1 µl Ne2 buffer 
2 µl HindIII      1 µl NdeI 
6 µl plasmid       3 µl plasmid 
10 µl water      5 µl water 
=20 µl total           =10 µl total 
 
**Then add 10 µl of the HindIII 20 µl to NdeI 
digest for total double digest of ~20 µl 
 
1. Incubate 1 hour at 37 degrees C 
2. Deactivate 20 min at 65 degrees C 
3. Load 5 µl each onto agarose gel with 1 µl 
6x dye added to each sample 
 
Point mutations were analyzed by single digests (see recipes for single digests above) to 
obtain verification of an intact plasmid size, but were only confirmed by sequencing.  Sequencing 
products for all possible mutants were prepared according to protocols from Genewiz.com.   
 
Transformation Into Expression Strain 
 Once the correct mutant had been identified through sequencing, the mini-prepped 
plasmid was then transformed by heat shock into BL21(DE3)pLysS cells.  50 µl of the competent 
cells were put on ice, and 50ng (~1 µl) of the R902A Mfd plasmid was added.  The sample was 
then placed on ice for 40 minutes, swirling the tubes about every five minutes.  It was then placed 
in a water bath at 42°C for 45 seconds, after which it was again placed on ice for 2 minutes.  
Then, 1 ml LB media was added to the sample, and the sample was incubated at 37°C for 1 hour 
at 200rpm.  Then, 150 µl of the sample was plated overnight on LB + ampicillin plates. 
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Mfd Protein Grow-ups and Induction 
 20 ml overnight cultures were grown with 50 µg/ml ampicillin (stock: 50 mg/ml) and 25 
µg/ml chloramphenicol (stock: 25 mg/ml) added for selection.   The cells used were 
BL21(DE3)pLysS cells containing the appropriate Mfd mutant.  The cells were grown overnight 
in a shaker (at 37° Celsius and 200 rpm).  The overnights were transferred to a falcon tube, spun 
down at 3000 rpm for 12 minutes, after which the supernatant was removed.  The pellet was re-
suspended in 20 ml fresh LB media.  We then added the pellet resuspension to 1 liter flasks of 
LB, with 50µg/ml ampicillin and 25 µg/ml chloramphenicol added for selection purposes.  The 
cells were grown until they reached an OD at 600nm of approximately 0.6-0.8.  Upon reaching 
this absorbance, the cells were induced to produce Mfd protein by induction with 0.5 mM IPTG.  
Three hours after induction, the cells were spun down for 10 minutes at 7,000 rpm and 10°C.  The 
wet weight of the pellet was measured and the pellet frozen at -20°C for up to a month. 
 
Protein Purification 
The frozen pellet was first resuspended in 30-40 ml of lysis buffer (10mM Tris pH=8.2, 
500mM NaCl).  The resuspended material was then passed through a microfluidizer 
(Microfluidics MFCI Corp) three times at 16K/70 PSI.  The solution was cleared by 
centrifugation at 17000 rpm in a GSA rotor for 30 minutes at 4°C.  The supernatant containing 
protein was recovered and filtered through a 0.22µm Millex® GP syringe driven filter unit 
(Millipore) for sterilization purposes.   
 
Affinity Chromatography 
 The first step used to purify each of the mutants was affinity chromatography using a 
batch bound, self-loading cobalt column (TALON metal affinity resin, Clontech Laboratories, 
Inc.).  The resin was used due to its higher specificity than the traditional Nickel column used 
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previously.  The cobalt core of the TALON® resin binds the His-tag with more specificity, 
minimizing contaminants.  Figure 3.3 shows the chemical structure of the cobalt chelator linked 
to the beads. 
 
 
 
 
The resin was loaded with protein in a batch binding protocol.  The filtered supernatant 
was added to about 2-3 ml of the TALON resin, which had been previously washed 3 times in 
lysis buffer (see protein purification above) to remove ethanol present from storage conditions.  
The binding time was between 20-30 minutes, and a Nutator device was used to rotate the 
mixture at 4°C for this time period.  Then a 5 ml column was loaded with the pre-bound protein 
to a column bed volume of ~2-3 ml.  A wash with lysis buffer was performed off-line.  Then the 
ACTA FPLC system was used to elute protein at a flow rate of 1 ml/min.  First, an additional 20 
column volume wash step was performed on-line using lysis buffer (buffer A: 10 mMTris, 500 
mMNaCl) followed by a gradient elution of 30 column volumes from 0-40% elution buffer 
(buffer B: 10 mMTris pH 8.2, 500 mMNaCl, 150 mMimidazole).  When trials were run with 
detergent, .1% Triton 102x was added to each of the buffers used.   
 
 
 
Figure 3.3:  Talon structure. 
Structure of the Talon resin is 
shown with the cobalt ion 
shown in red interacting with 
the C terminal polyhistidine 
tag of the protein. From the 
Clontech brochure. 
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After purification by cobalt column, imidazole was removed from the protein using the 
HiTrap™ 5mL desalting column (HiTrap desalting, Amersham).  The column was equilibrated 
with 25mL lysis buffer at 5ml/min using a 5 ml syringe, and 1.5ml of the sample was run through 
the column.  The fractions were eluted with 2 ml lysis buffer.  Fractions of high purity were taken 
directly from this step for proteolysis experiments and ATPase coupled assays.   
 
Ion-Exchange Chromatography 
Ion exchange was on a 1 ml Hitrap QFF column (Amersham), and the purification was 
done using the ACTA-FPLC system.  The column was equilibrated with buffer A (20mM Tris 
pH=8, 2mM DTT), sample was bound (at 50 mMNaCl) and eluted with buffer B (20mM Tris 
pH=8, 2 mM DTT, 1 M NaCl).  Flow rates were 0.5 ml/min throughout.  Wash was done with 10 
column volumes and buffer A.  Elution was 24 column volumes of 0-100%B.  Alternatively, a 
UNO-Q1 column was used with the same buffers.  A wash was done for 10 column volumes 
followed by elution with 100 column volumes from 0-50% B at a flow rate of 0.5 ml/min.   
  
Size-Exclusion/ Gel Filtration 
A S200 sizing column was used with a 9 ml bed.  After equilibrating the column, about 
200 µL of sample was loaded onto the column, and eluted at a flowrate of 0.5 ml/min.  Lysis 
buffer (10 mMTris pH 8.2, 500 mMNaCl) was used.When trials were run with detergent, .1% 
Triton 102x was added to each of the buffers used.  
 
Assessing Protein Purity and Concentration  
Proteins were analyzed for purity by SDS-PAGE using a  Mini-gel3 system (Biorad).  
Gels were run through the stacking gel at 100 volts, and then through the running gel at 150 volts 
for better gel separation and band appearance.  The gels were stained with Gelcode Blue Stain 
Reagent (Pierce).  The gels used were 10% SDS gels, made according to the manufacturers 
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protocol (Biorad). Concentration of protein purified was calculated using the absorbance at 280 
nm with background measurement at 319nm subtracted (measured using a single beam UV 
spectrophotometer, from Thermo Electron Corporation).  The concentration values were based on 
Lambert-Beer’s law, A =ε c l, where ε for Mfd was estimated as 0.734 cm/(mg/ml) at a 
wavelength of 280nm from the primary sequence (Gasteiger et al. 2005, 
http://ca.expasy.org/tools/protparam.html) and the path length l was 1 cm. 
 
Concentrating Protein 
 Multiple methods of concentration were attempted on the mutant proteins.  Microcon 
filters and centricon filters were both attempted, spinning lysis buffer through to wash the filters, 
and then concentrating the protein at 4500 g for 20 minute time intervals.  The microcons were 
inverted and spun at 500 g for 2 minutes to accumulate the concentrated sample.  With limited 
success, other methods of concentrating were used including ammonium sulfate precipitation and 
PEG precipitation.  Ammonium sulfate precipitations were performed by adding 3.59 g of 
ammonium sulfate gradually to a pooled 8 ml desalted protein sample.  The samples were set on 
ice for 30 min to 1 hour with occasional stirring.  The sample was then spun down at 4 degrees C 
for 30 minutes at 4500 g.  The resulting supernatant was discarded and the pellet resuspended in 
the desired volume of lysis buffer.  PEG precipitation was performed by adding equal volumes of 
both the protein and a 50% PEG solution.  Then, the protocol is the same as the one followed for 
the ammonium sulfate precipitation. 
 
Pull-down Assay with Nickel beads 
 Undigested and digested samples of the cleavable 450tev-Mfd protein were obtained 
through purification and proteolysis.  Approximately 30 µL of Qiagen nickel-NTA beads were 
used for each sample.  The beads were washed with water and then binding buffer (low salt lysis 
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buffer: 100 mMNaCl, 10mM tris pH=8.2).  Then, 60 µL was added to 420 µL buffer and the 
beads.  The mixture was incubated with slight mixing for 30 minutes.  Then the beads were 
allowed to setttle on the bottom of the tube, and the supernatant was transferred to a YM-10 
microcon filter (Millipore) and concentrated at 10,000 g’s for 30 minutes.  This sample was saved 
as “supernatant”.  The beads, meanwhile, were washed twice with buffer and again, the 
supernatant was removed and saved as the “wash” sample.  Finally, the bound protein was eluted 
from the beads by adding elution buffer made of a 9:1 mixture of binding buffer and 0.5M EDTA 
for a final concentration of 50mM EDTA.  This was left for a couple minutes and saved as the 
elution fraction.  All samples from undigested and digested were run on a SDS-PAGE gel.   
 
ATPase Coupled Assay 
The coupled assay measures the depletion of NADH to form NAD+ as ATP is 
regenerated after hydrolysis to ADP.  In the net reaction, for every molecule of ATP hydrolyzed, 
one molecule of NADH is oxidized to NAD+. The ATP regeneration is based on phosphate 
transfer from PEP (phosphoenolpyruvate) to ADP by PK (pyruvatekinase), forming ATP and 
pyruvate. In the second step of the coupled assay, pyruvate is reduced and NADH oxidized by 
LDH (lactate dehydrogenase), forming lactate and NAD+. Since ATP does not absorb at a useful 
wavelength but NADH does, we can measure the depletion of NADH at 340nm using a UV 
spectrophotometer and use the 1:1 stochiometry to calculate the rate of ATP hydrolysis.  I 
averaged the slopes of the graphs showing the raw UV-absorption trace of NADH depletion over 
10 minutes and determine the rate by dividing the average slope (per minute) by ε=6.22 mM-1cm-
1
 (the extinction coefficient of NADH at 340nm).  This gives the rate of ATP hydrolysis (units: 
mM/min).  Then we can calculate the turnover rate (units: 1/min) of the enzyme investigated by 
dividing the rate by the concentration of protein used (in molar units).   
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The instrument used was the Beckman DU800 UV-vis spectrometer, and the pathlength 
was set to 1 cm.  The wavelength used for absorbance is 340 nm because NADH has a 
measurable absorbance at this wavelength without interference from any other components in the 
reaction mixture.  Thus, the concentration of NADH used was approximately 0.2 mM (giving a 
theoretical absorbance of 1.24 at the beginning of the reaction), and the concentration of ATP was 
approximately 4 mM (well above the Km of approximately 1mM, Peng Gong, personal 
communication).   The experimental set up is shown in table 2 (assay optimization performed by 
Mike Murphy).
Figure 3.4: ATPase Coupled Assay.  This diagram shows exactly how we 
can couple the depletion of NADH to the hydrolysis of ATP, using a coupled 
enzyme system.  Each intermediate is shown, and the coupling is done in a 1:1 
ratio of NADH to ATP.  As a net effect, regeneration of ATP (hydrolyzed to 
ADP by the enzyme of interest, here the motor domains of Mfd) is coupled to 
the depletion of NADH.   
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Sample Buffer (prepared 1st) 
Components Stock solution conc. Volume added 
HEPES pH 7.5 1 M 160 µL 
Glycerol 100% 160 µL 
MgCl2 1 M 40 µL 
DTT 100 mM 160 µL 
ATP 100 mM 160 µL 
dd water  520 µL 
TOTAL  1200 µL 
 Coupling Reagents (prepared 2nd) 
Components Stock solution conc. Volume added 
PEP 25 mM 600 µL 
NADH 10 mM 60 µL 
PK-LDH 0.727 U/µL -1.1u/µL 98.4 µL 
dd water  741 µL 
 
Next, add each of the volumes of reagents in the Volume Added 
Components Stock solution conc. Volume added Final conc in 100µL 
Sample Buffer  30 µL  
HEPES pH 7.5 (see above)  40 mM 
Glycerol (see above) 4% (v/v) 
MgCl2 (see above) 10 mM 
DTT (see above) 4 mM 
ATP (see above) 4 mM 
Coupling Reagents  50 µL  
PEP (see above) 
 
5 mM 
PK-LDH (see above) 0.024u/µL-
0.036u/µL 
NADH (see above) 0.2 mM 
Now incubate for 1 minute at 37 °C, then add your Sample 
Protein or  
Lysis Buffer 
0.5 M NaCl, 
10 mMtris, pH 8.2 
20 µL 100 mMNaCl, 
1 mMtris pH 8.2 
then measure ATPase Activity over time 
**blanked the instrument with 30 µL of Sample Buffer + 20 µL of Lysis Buffer + 50 µL of dd water.     
**control samples are 30 µL of Sample Buffer + 50 µL of Coupling Reagents + 20 µL of Lysis Buffer 
 
Table 2: Coupled Assay Setup:  The above tables summarize the finalized 
ATP assay utilized in experiments.  Variations of this protocol were used in 
preliminary ATPase studies but were further optimized for future experiments. 
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Proteolysis Reactions 
 
  Table 3: Proteolysis Reactions Recipe 
Reagent Undigested sample Digested sample 
Protein sample (µL) 15 15 
20X TEV buffer (µL) 3.75 3.75 
100 mM DTT (µL) 1 1 
*Lysis buffer (µL) 55.25 55.25 
10 U/ul TEV protease (µL) 0 1 
TOTAL rxn volume (µL) 75 75 
 
Note that master mixes were made for consistency when using multiple samples and 
comparing them to each other.  The lysis buffer used was 10 mMTris pH 8.2, 500mM NaCl.  *In 
some of the earlier proteolysis experiments, distilled water was used instead of lysis buffer.  Lysis 
buffer keeps the salt concentration high enough during subsequent ATP assays of the samples 
digested.  After reagents are added, they are left at room temperature.  At set time points (4,8,24 
or 1,2,4 hours) 10 µL of each of the samples, undigested and digested, were quenched with 5 ul 
of a 3x SDS loading buffer and frozen for future electrophoresis (with all the time point samples). 
 
PEGylation Protocol: 
A prequenched sample was run as a control by mixing 5 µL 1 M DTT with 15 µL of the 
PEG-mal reagent (20% w/v).  The mixture was incubated at room temperature for 5 minutes, and 
then 10 µL of the protein sample was added.  For experimental samples, 10 µL protein sample 
was mixed with 15 µL peg-mal and 5 µL water for intact protein modification.  5 µL of a 10% 
SDS solution was added instead of water in order to denature the protein for full PEGylation.  
These test samples were incubated for an hour, after which 5 µL of a 1M DTT solution were 
added.  10 µL of each of the samples were mixed with 5 µL of a 3X SDS loading buffer sample 
to run on a 10% SDS-PAGE gel.  
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CHAPTER IV 
RESULTS AND DISCUSSION 
Pull Down of 450tev (cleavable Mfd) 
To test the strength of MfdN: MfdC interactions, I made use of the C-terminal His-tag present on 
the cleavable 450tev-Mfd construct. Protein was cleaved, the product incubated with Ni-NTA beads, 
supernatant was removed and the beads were washed and treated with EDTA to elute bound protein. 
 
The pull down assay shown in Figure 4.1 represents a preliminary experiment done with 
fairly impure 450tev Mfd sample (cleavable full length Mfd).  The samples contained a few 
contaminants but the results were still clean in the gel readout.  The starting sample is shown in 
the control lanes “no proteolysis”.  In the proteolysis lane, you can clearly see the appearance of 
two distinct bands corresponding to the molecular weights of the two products of proteolysis, 
Mfd-N and Mfd-C.  The pull down experiment effectively bound the species of protein that 
contained the poly-histidine tag (both the remaining full length Mfd from the incomplete 
proteolysis and Mfd-C).  Mfd-N came off in the supernatant, as it could not bind the nickel beads 
and did not bind sufficiently strongly to Mfd-C to be pulled down with it.  The fact that Mfd-N 
did not interact with Mfd-C after proteolysis indicates that Mfd-N and Mfd-C do not interact 
Figure 4.1: Pull down 
results for 450tev 
Mfd.Mfd-N of the protease 
treated sample could be 
pulled down with nickel 
beads after proteolysis, 
indicating that under the 
pull-down conditions, it 
has no other associations 
with Mfd-C besides 
through the flexible linker 
region (which was severed 
with TEV proteolysis of 
the cleavable mutant).   
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strongly other than though the linker. 
 
Creation of 804D Mutant 
 As described in detail in Chapter II, Mfd mutants that disrupt the MfdN: MfdC interface are 
desirable reagents to test the open conformation hypothesis and conduct other experiments designed to 
elucidate the molecular mechanism of transcription-coupled repair. The Arg804 to Asp mutant is predicted 
to disrupt a positively charged patch on domain 6 of MfdC that interacts with a negatively charged patch on 
domain 1 of MfdN.  The 804D mutant was made by Quikchange mutagenesis and subsequently 
verified by DNA sequencing.  Cells harboring the mutant expression plasmid grew under 
selection of the appropriate antibiotics and had a clear induction when samples were taken at 
different time points and analyzed to test for an increase in Mfd protein.  Figure 4.2 shows two 
separate induction profiles for the 804D mutant, with the 804D protein amounts increasing over 
time.   
 
 
Figure 4.2: Induction 
Samples.  The two sets of 
induction samples represent 
two separate liter growths of 
the R804D mutant.  The 
increase in protein at the Mfd 
position near the 135kD 
marker is apparent in both.   
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Purification of 804D 
Soluble protein of 804D-Mfd was obtained, as evident by purification gels showing 
protein in the elution fractions, and the absence of any visible precipitation during purification.  
In past purifications in the lab, there was an issue purifying Mfd from E.colibecause of the 
presence of a characteristic contaminant that binds nickel columns with high affinity.  
Unfortunately, I also encountered this issue with nickel column purification of 804D.  HiTrap 
Nickel columns copurified a distinct protein at 70 kD along with my Mfd mutant (figure 4.3) 
 
 
The contaminant would not be such an issue if not for the need for future analysis of 
proteolysis gels.  Cleavable forms of Mfd are cut into MfdC and MfdN, which are ~80 and 55 
kDa respectively.  The presence of contaminants in this region of the gel impairs our ability to 
analyze results, and could be quite troublesome in purification.  The solution was found by 
utilizing the Talon Cobalt beads discussed earlier in the methods section.  This method proved to 
eliminate many of the high molecular weight contaminants that were such a point of frustration.  
Figure 4.4 shows a representative cobalt column purification of 804D protein. 
Figure 4.3:  Nickel Column Purification 
of 804D.  My protein is the top band 
shown on the gel above.  Note the 
presence of the ~70kD contaminant that 
elutes along below my protein.  Also note 
that the relative amount of the contaminant 
in the first few lanes is very high.   
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The first thing I noticed about the cobalt column purifications was that the protein began 
eluting at only 7% B (for a sample chromatogram with corresponding gel, see Figure 4.12), which 
corresponded to an imidazole concentration of only 10 mM.  Variations of the elution gradient 
from the method discussed proved further that the 804D mutant seems to come off the column all 
along the gradient no matter what the gradient’s length.  I tried ion exchange columns after the 
cobalt column, but it proved to be not very much help in removing the few contaminants of the 
cobalt column.  I concluded from this that further purification was not necessary due to the fairly 
pure nature of the later fractions from the cobalt column, as well as the fact that further 
purification just seemed to dilute my protein.  Due to the fact that I had problems concentrating 
protein (see concentration issues section), it seemed to be unnecessary to dilute my protein further 
for no real gain in purity.   
   
Figure 4.4:  Cobalt Column Purification of 804D.  The 
protein elutes all along the gradient, but we do get relatively 
pure, concentrated protein near the end of the gradient. 
A.   
B. 
    
 
 
 
 
 
Concentration and Degradation Issues
 When I tried to concentrate my protein after purification, I realized that my protein could 
be aggregating.  The protein seemed to elute all along any gradient and any form of purification I 
attempted, from nickel to cobalt to ion exchange columns.  I used microcon filters for purification 
of some of my very pure samples from a cobalt column that had been desalted, and I effectively 
lost all of my protein on the membrane (see figure 4.6).  
Figure 4.5:  Ion Exchange Purification.
fractions from a QFF run analyzed on SDS
run where the protein was eluted at much slower gradient, but still 
provided little additional purity.  
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  (A) shows an example of 
-PAGE.  (B) shows an UnoQ1 
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Other attempts were not so dramatic, losing only a little protein or maintaining a constant 
concentration of protein when monitoring OD at 280nm over the time of attempted concentration.  
I added more and more protein sample to the filters and saw no increases in concentration.  I 
followed up on this problem by performing gel filtration on my protein samples, both to see 
where it ran on the column compared to known standards, and also to see if I could get further 
purity from my samples.   
Figure 4.6:  Concentrating Problems.  The samples on the left 
were concentrated and run on a gel, with no recovery.  The gel on 
the right shows what was obtained off of the filters when boiled.  
As show, all the protein stuck to the filters during concentration.   
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As shown in the gel in Figure 4.7, pure sample was obtained from gel filtration, but at 
very low concentrations.  With trouble concentrating the protein, this made it difficult to use these 
pure samples for any further experiments.  The gel filtration shows that 804D runs almost in the 
void volume between a 2000 kDa and a 200 kDa standard instead of at its molecular weight of 
130 kDa, indicating possible aggregation.  I then ran 450tev on gel filtration for comparison, and 
it ran exactly the same, with the peak eluting at an identical point.  I tried to address the 
aggregation problem by performing cobalt column purification with detergent added, and then gel 
filtration with detergent added.  I was hoping to see elution at a further point in the run 
corresponding to the size of Mfd, but I saw instead inverse peaks at the same points as before, 
indicating that the detergent levels may have been too high and that micelles were forming.  I did 
the exact same purifications with detergent added for 450tev as well, and saw similar results.   
Figure 4.7:  Gel Filtration of 804D.  The chromatogram shows that 804D 
runs in the void volume, which indicates protein aggregation. Top left: 
SDS-PAGE of eluted fraction, top right: chromatogram, bottom: overlay 
of chromatogram with runs of molecular weight standards, with peaks 
labeled by molecular weight. 
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I also attempted some other methods of concentrating the protein, including two forms of 
precipitation: ammonium sulfate precipitation and PEG precipitation.  I got limited success from 
the ammonium sulfate precipitation, but not consistently.  The maximum concentration of the 
804D mutant I achieved was 0.25 mg/ml (1.9 µM).   
 
 
 
Another problem I had to address as well was the fact that my protein, in the presence of 
multiple contaminants, is not very stable over time when stored at 4 °C.  The protein degraded 
over time, as seen in figure 4.9.  However, with further analysis, it seemed that this degradation 
only occurred when the sample had high levels of contaminants initially, such as the one shown.  
A solution to continuing degradation problems could be the use of protease inhibitors, for 
proteases may be hydrolyzing the samples.   
 
 
Figure 4.8:  Other Concentration Methods.  
The pre-concentrated sample is shown in the 
first lane, followed by the concentrated 
sample obtained by A.S (ammonium sulfate 
precipitation) and the sample obtained from 
PEG-precipitation.  PEG-precipitation 
appeared to be unsuccessful. 
Figure 4.9:  Degradation at 4 °C.  
This shows the degradation of a 
sample of 804D (highly impure) 
over time when stored at 4 °C.  As 
indicated by the red circle, there is 
basically no protein left after 6 
days.   
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Initial TEV Proteolysis Data 
I decided that instead of continuing my efforts to achieve higher protein concentrations, I 
wanted to use the protein that I had (though it was fairly dilute) and try some of the experiments 
on proteolysis.  I took desalted protein samples and used them directly in the proteolysis 
experiments, performed as discussed in the methods section.  The protein typically had a 
concentration of 0.1 mg/ml (approximately 0.75 µM). 
 
 
 
 
Initial ATPase Assays 
 Initial Assays were performed comparing 450tev to 804D.  However, the results (not 
shown) were problematic.  Low enzyme concentrations had to be used, due to difficulties in 
concentrating the protein.  High background readings were comparable to the low rates, and there 
was low reproducibility with multiple trials.  Further work was done comparing all mutants when 
the assay was optimized a bit, as discussed later.   
Figure 4.10: Preliminary Proteolysis 
comparing 450tev to 804D.  The results 
indicate that in the 24 hour digestion period, 
more 804D protein is cut than 450tev.  This 
indicates an increased cleavage rate of 804D.  
Red boxes highlight the series that were used 
for the quantification.   
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Creation of the Delta7 Mutant 
From the initial TEV protease and ATPase data obtained for the 804D mutant, it was not 
clear if this mutant had the predicted large effects on MfdN: MfdC interactions.  I decided to 
work on a delta7 mutant of the cleavable Mfd because it was already published that that deleting 
domain 7 from wildtypeMfd caused an increase in ATPase activity of about 5-fold (Smith et al 
2007).  We wanted to see what effect deleting domain 7 would have on proteolysis rates in the 
context of the cleavable 450tev Mfd mutant.  We also wanted to look at ATPase activity of our 
full length mutant compared with the cleaved mutant, to try and understand the ATP inhibiting 
effect of domain 7 (seen by Smith et al 2007).  A side-by-side comparison of uncleaved vs. 
cleaved protein is possible in these cleavable mutants.  Because effects of mutations can be 
analyzed in the presence and the absence of MfdN: MfdC interactions, these reagents are 
powerful tools to study the Mfd mechanism.  
Delta7 was made through inverse PCR, verified through a set of digests (see figure 4.11) 
 
The protein expressed well and maintained solubility, throughout purifications.  I used an 
optimized purification scheme where I performed the batch binding and cobalt column 
purification in the same way as for the 804D mutant.  The proteins behaved similarly in both this 
step as well as in gel filtration, where delta7 also ran near the void volume at the same point as 
both 450tev and 804D.  This indicates that there are issues of aggregation for all three TEV 
protease cleavable constructs, as each ran near the void on a gel filtration column.   
Figure 4.11: Formation of ∆7 
Mutant.  I performed single and 
double digests of the potential 
mutants to see what one had a gel 
shift of the double digest fragment 
corresponding to the deletion of 
domain 7.  The sample circled in 
red had this shift of about 450 bp 
(corresponding to 150 amino acids 
deleted). 
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Proteolysis with Cleavable Constructs 
The proteolysis experiments are powerful due to internal controls.  We can compare the 
amounts of protein, as well as the sum of proteins present in each individual lane.  Quantifying 
the amount of TEV protease on a gel (~24 kD) is especially useful as a loading control in that it 
does not change concentration over time, providing a check on any pipetting errors.  Using a 
master mix containing protease for the digested samples minimizes this, but band quantification 
of the protease still provides a good check on our ability to compare different proteins’ 
proteolysis rates (as an internal control). 
 
Figure 4.12: Cobalt Purification comparing 804D to ∆7.   
As shown, the two mutants behaved very similarly when 
eluting from a cobalt column.  
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Preliminary ∆7 Proteolysis data 
 A preliminary proteolysis was done comparing ∆7 to 450tev, and I saw clearly on a gel 
that ∆7 was cut faster (Figure 4.13).  However, the bands for the protease were more intense for 
the ∆7 lanes, indicating a pipetting error that led to more protease being added to the ∆7 sample.  
Although the results were somewhat compromised due to this pipetting error, the experiment 
showed that the time points for the proteolysis should be at shorter values.  By four hours, the 
entire sample of 804D was gone.  We believe the change was because we were using a 
commercially bought TEV protease for previous experiments (see Figure 4.10).  When the 
commercial sample was used up, I started using TEV protease produced in the lab from stock 
solutions kept at -80 °C at a concentration of 0.9 mg/ml (generously provided by Mike Murphy).    
 
 
 
 
 
 
Figure 4.13:  Preliminary ∆7 Proteolysis.  From initial runs, 
I determined that due to a more active protease sample, I 
needed to change my time points of proteolysis to shorter 
increments.  Note in this gel that a master mix was not used, 
and the protease bands seem to be darker for ∆7.  This may 
be why ∆7 is completely digested by 4 hours.    
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Comparing 450tev/804D/∆7 
Proteolysis reactions were performed as described, with samples taken after 1, 2, and 4 
hours.  Many different runs were done to improve the readout.  One of the 1st sets of proteolysis 
reactions indicated that both 804D and ∆7 were cut faster than 450tev.  This result indicates that 
in these mutants, the interface between N and C has been disrupted, and the protein has opened 
up, exposing the linker to increased proteolysis.  However, this effect was only seen a couple 
times out of many runs, and the difference was not great (see Figure 4.14).  Figures 4.14, 4.15, 
4.16 show the experiment in triplicate. 
 
 
 
 
 
Figure 4.14:  Proteolysis 
comparison #1.  In this 
particular experiment, both 
804D and ∆7 have 
increased proteolysis over 
time compared to 450tev.  
By 4 hours, there isn’t 
much of a variation, with 
between 5 and 13% 
protein remaining.  
However, there is a 
recognizable difference 
after 1 hour proteolysis, 
when 450tev has 46% full 
length remaining, while 
804D and ∆7 are digested 
to a larger degree.   
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These results and the majority of other trials indicate that proteolysis is effectively the 
same for each mutant.  Even in the trials where there is a difference, it is not very substantial.  
Therefore, this indicates that proteolysis rates may not provide the best readout for openness, and 
may not be able to be used as a sensor for conformational change.   
 
 
 
Figure 4.15:  Proteolysis comparison #2.  No apparent differences in rates of 
proteolysis between samples can be seen.   
Figure 4.16:  Proteolysis comparison #3. No apparent differences in rates of 
proteolysis between samples can be seen. 
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ATPase Assay with Cleavable Constructs 
 I used samples obtained from the proteolysis reactions for each of the mutants in 
subsequent ATPase assays.  For round #1 (see summary of results, Figure 4.18), I took samples 
that had been undergoing proteolysis for about a week at room temperature.  Also note that the 
final concentration of NaCl for this round of ATPase assays was only 60 mM (realized later as a 
very low salt concentration, especially for an aggregation-prone set of Mfd mutants).  For the 
second round of samples (see summary of results, Figure 4.20), I adjusted NaCl concentration to 
a final concentration of 100 mM to improve results.  Also, I included an Mfd-C sample for 
comparison, and I used proteolysis samples that had only been reacting with protease and sitting 
at room temperature for 48 hours.  Discrepancies between the two sets of data may be attributable 
to either of these issues: either the low salt concentrations in round one, or degradation/ loss of 
activity of proteins in round one due to incubation at room temperature for such a long period.  
See Figure 4.17 for examples of the raw UV traces obtained for 2 different samples, 804D 
digested and the control.  I obtained reproducible trial data for each sample, as shown by the 
similar slopes for each sample from trial to trial. 
 
 
 
 
  The concern for both rounds of ATPaseasays
showed a rate that was comparable (slightly lower) than the lowest readings of the tested samples.  
This causes a problem when the value for the control rate is falsely interpreted/read as a 
substantial part of the ATPase activity of the protein.  The high reading of the control sample 
(which has everything except Mfd sample added) may be due to a spontaneous breakdown of 
ATP in the sample.  I performed experiments with no enzyme (no coupling enzyme or ATPase) 
in the sample and saw similar background rates.  This indicates that perhaps there is a 
spontaneous breakdown of NADH.   The background rate provides a major source of concern 
when measuring samples with little activity at low concentrations.  However, for samples
MfdC run in round #2, the small background has little effect.  The solution may be to try and 
UV traces for 804D digested samples
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Figure 4.17:  Examples 
of Raw UV traces.
top graph shows four 
trials performed on 804D 
after digestion.  Below 
shows four trials 
performed on the control 
sample.  It is important 
to note that the control 
samples have a 
significant rate  
(especially compared to 
the undigested samples 
of 450tev and 
not shown).  
 like the 
  The 
∆7, data 
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obtain more concentrated samples that will give a higher readout that is well above background 
readings.  Other solutions include trying to optimize reagents and see if lower control rates can be 
obtained by using better stock solutions.   
 Turnover rates were calculated as the rate of ATP depletion over the concentration of the 
protein used in the assay.  Turnover rates are shown in both Figure 4.18 and Figure 4.20.   
 
 
 
  
 
The results from round 1, shown in Figure 4.18, indicate a substantial effect of the 804D 
mutant.  The activation between undigested and digested 450tev is not consistent with our 
expectations of a highly activated cut sample (based on the large activation seen when comparing 
wildtypeMfd to Mfd-C).  However, 450tev is already slightly activated when compared to 
wildtypeMfd (Theis lab, unpublished data).  The activation caused by introducing the TEV cut 
site into the full length protein is between 3 and 5 fold (varying results from different trials).  
Figure 4.18:  Round #1 turnover rates for cleavable mutants.  The NaCl 
concentration in the assay was 60mM.  These results show a similarity between 
450tev and ∆7 mutants when comparing rates of undigested and digested samples 
(1.7-fold enhancement upon digestion in both 450tev and ∆7).  Quite amazingly, 
804D samples show no activation upon digestion, indicating the successful 
formation of a hyperactive mutant form of Mfd.  However, it was puzzling that 
digested and undigested 804D showed higher rates than cut 450 (which should 
represent the high activity seen in Mfd-C). 
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Therefore, any additional activation (such as cleavage to a highly active Mfd-C) may not be quite 
as dramatic as expected.  However, we do expect the cleaved 450tev to have rates comparable (or 
even identical) to Mfd-C because they are exactly the same protein after cleavage occurs.  This is 
addressed in round 2 when Mfd-C was assayed alongside the other mutants for comparison 
purposes.   
As previously stated, the salt concentration in round #2 of the ATPase assays was 
increased from 60 mM to 100 mM.  I also used samples that were newly digested, and I was more 
meticulous in my analysis of the concentrations of each of the samples.  The issue of 
concentration in these assays is a problem, in that concentrations of proteins are taken from UV 
(280 nm minus 319nm OD’s) absorbances, which are not highly dependable at the low 
concentrations I used.  The concentration assigned to each of the samples is utilized directly in 
the calculation of turnover rates.  If the concentration is off, the turnover rates represent the error, 
and comparisons between mutants are troublesome.  However, the undigested vs. digested 
samples of the same protein represent a dependable comparison, as the samples are subjected to 
the same treatment and taken from the exact same sample.  This type of comparison is an 
extremely useful and powerful property of the cleavable mutants.   
Many of the samples in both rounds of ATPase assays had high baseline readings around 
319 nm, which indicates the potential for increased inaccuracy in the reading.  For the 2nd round 
of samples, I ran the undigested and digested samples of each protein tested on a gel to see if I 
could compare the amounts of protein through quantification of bands and perhaps use this 
secondary method as a way of checking and estimating the various concentrations of protein.  
This method seemed to be useful in determining how much protein was present.  Due to all these 
considerations, I believe the round #2 ATPase assays (Figure 4.20) represents a more dependable 
data set.   
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Figure 4.19:  Gel of samples used for round #2 ATPase assays.  For this round of assays, I 
used freshly digested samples.  This gel was used to verify amounts of protein used in the 
assay as well as the extent of digestion of each of the samples.  The digested samples run on 
the gel were digested for 24 hours (and compared to undigested samples).  Because traces of 
the full length proteins were present in the 24 hour samples, samples were digested for an 
additional 24 hours before ATPase assays were performed, to be certain each sample was 
adequately digested.  MfdC was run in the absence and presence of protease in order to have 
samples treated identically before use in ATPase assays.   
Figure 4.20:  Round #2 turnover rates of cleavable mutants.  The NaCl 
concentration in the assay was 100 mM.  These results varied substantially from round 
#1 samples in various respects.  804D samples were fairly comparable, but digested 
804D was activated compared to undigested.  ∆7 samples showed almost identical 
results, with low undigested activity and little activation.  However, the 450tev 
digested sample increased about 100-fold from the full length sample.  The rate of the 
digested 450tev, predicted to be identical to the Mfd-C run, was within a factor of 2 of 
the rate of Mfd-C. 
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The uncleaved 450tev had an extremely low activity, and the cut 450tev (which should 
resemble MfdC because the sequence of Mfd-C and cut 450tev are identical except for the N-
terminal methionine present in Mfd-C) has an approximate 100-fold increase from the uncleaved 
(which is similar to the large turnover rate seen for MfdC).  804D undigested is activated by a 
factor of about 8 compared to 450tev undigested and the digested 804D is activated 2-fold from 
the undigested 804D (but note that this increase is not significant given the standard deviations of 
the pair of measurements).  This indicates that the 804D mutation successfully creates a partially 
hyperactive mutant capable of increased ATP hydrolysis.  However, digested 804D shows a 
decrease in activity compared to digested 450tev, indicating that the effect of the mutation on 
ATPase activity is linked to some sort of association with the N-terminus. The difference between 
100 fold activation by 450tev cleaved vs. uncleaved and 2 fold activation by 804D cleaved vs. 
uncleaved indicates that the 804D mutant causes a significant change in protein activity.  We 
think that this is due to a destabilization of the interface of Mfd that causes partial (if not 
complete) opening of the protein and subsequent activation.   
The ∆7 mutant showed a slight increase over 450tev full length.  This increase was also 
seen in the work by the Savery lab, working on ∆7 of the wildtype (Smith et al 2007).  However, 
the activation achieved upon 450tev cleavage was not achieved by the ∆7 mutant upon cleavage.  
This indicates that domain 7 in the full length protein inhibits ATPase activity through 
interactions with Mfd-N.  When domain 7 is removed from the full length protein, there is an 
activation of ATPase activity.  However, the expected increase of activity is not observed when 
comparing Mfd-C to cleaved ∆7.  Digested ∆7 shows only a 3-fold increase compared to 450tev’s 
100-fold increase, indicating that something about isolating Mfd-C∆7 (through digesting ∆7) 
decreases the amount of activation normally observed upon cleavage of the wildtype protein.  
Perhaps activation is not achieved through complete opening of the protein, but just through 
changes that result in an altered association with Mfd-N that causes activation.  In summary, we 
54 
conclude that removing domain 7 results in increased activity only in the context of full length 
protein where Mfd-N: Mfd-C interactions play a role. 
 My results for the cleavable ∆7 Mfd mutant do not seem to support the role of domain 7 
suggested by the Savery lab. Their model, based on 5-fold activation of wildtype Mfd upon 
deletion of domain ∆7, is that domain 7 somehow hinders motions of the motor domains by 
interacting with the helical extensions extruding from them (Smith et al 2007). In contrast, our 
open conformation hypothesis predicts that Mfd-N: Mfd-C interactions hinder motions of the 
motor domains, and weakening these interactions at any location within the interface will 
correlate with increased ATPase activity. Our comparison between cleaved and uncleaved Mfd, 
both in the presence and absence of domain 7, confirms this prediction. It is important to note that 
the cleavable form of the wildtype protein shows significantly different properties than the 
wildtype, in that its ATPase activity is already activated.  Therefore, the smaller increase seen in 
my data between 450tev and ∆7 (both undigested) compared to the published 5-fold increase 
upon domain 7 deletion (Smith et al 2007) may be due to the fact that it has already been 
activated to a degree by the insertion of amino acids into the linker. 
55 
PEGylation Results 
I attempted the experiment outlined in figure 2.8 with variations of the full length 
cleavable Mfd.  However, I was unsuccessful in obtaining clear readouts, and could not visualize 
separate bands representing PEGmal-modified samples.  Experiments were performed with both 
450tev as well as the 401C mutant and could not see any differences between them, due to the 
unclear readout.  I decided to simplify the experiment and attempt a PEGylation reaction on just 
the N-terminal fragment of Mfd, hoping to establish a clear number of cysteine residues that 
could be modified by PEGmal.  I ran a prequenched sample representing the Mfd-N with no 
modification.  Then I ran a sample of modified in tact Mfd-N (-SDS) and another of modified 
Mfd-N in the presence of a denaturant (+SDS).  The results are shown in figure 4.21 
 
 
Overall the results indicated that the samples were modified differently in the intact vs. 
denatured forms.  This is apparant in figure 4.21, as the +SDS lane has higher molecular weight 
species, indicating increased PEGylation and therefore, accessibility of cysteine residues.  The –
SDS sample seems to have about 4 bands (maybe 5?).  This correlates with the fact that Mfd-N 
has 3 cysteine residues, so the bands represent the unmodified protein and then 3 modified 
versions.  The further modifications found in the +SDS sample are confusing, as there are no 
more available cysteines to modify.   However, PEGmal can also react with primary amines 
under certain conditions, so we may be seeing the effect of other modifications.  The important 
Figure 4.21:  PEGylation Gel.  
This gel shows the prequenched, 
unmodified Mfd-N as well as 
samples modified in the presence 
and absence of SDS.  The distinct 
bands indicate that PEGmal 
modification can be seen on a gel 
and provide information on the 
state of the protein in question.   
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thing is that we could obtain a clear readout of distinct bands corresponding to modification.  
Future experiments would include using mass spectroscopy to determine the molecular weight of 
the various species seen on the gel.  Tryptic digest prior to mass spectroscopy analysis would 
provide more information about the location of the modification (if any) in the protein.   
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CHAPTER V 
CONCLUSIONS / FUTURE WORK 
 
To study conformational change in Mfd underlying its activation, I used the 450tev-Mfd 
mutant, in which a TEV protease site was introduced into the linker region.  I then created the 
R804D point mutation as well as the large scale deletion mutant, ∆7.  Overall, the goal of this 
study was to create mutant versions of the Mfd motor DNA repair protein in order to use these 
mutants to study the conformational changes that occur in Mfd.  Analyzing how Mfd changes 
conformation over the course of its functioning as a coupling factor in transcription coupled 
repair can provide insight into understanding DNA repair as a basis for new treatments and 
prevention of disease.  
Some confusing points about my final data include the major point of why the cleaved 
450tev mutant doesn’t have the same ATPase rates as the Mfd-C protein expressed alone and 
assayed under identical conditions (Figure 4.20).  The cleaved version of 450tev should be 
identical to Mfd-C in its properties, so this is something to be studied further.  However, cleaved 
450tev was comparable to Mfd-C, and the difference may just represent a variation of conditions 
encountered in the assay, or the amount of functional or active protein in each of the samples.  
The proteins were purified on different days and are subject to variations encountered in any 
biological assay.  Other pitfalls include the fact that the ATPase assay seems to be at the limit of 
detection.  The control samples, which should have no activity, have a rate comparable to some of 
the undigested samples that were analyzed.  For data analysis, these control rates were subtracted 
from the test rates for the samples to standardize the results.  It seems that the solution for the 
high relative background reading for some of the less active samples would be to obtain highly 
concentrated samples that have ATPase activity that is significantly above this background rate.  
This way, the readout for the assay would be stronger, and therefore the assay would be much 
more dependable.   
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Proteolysis rates do not seem to provide the best readout for conformational changes 
according to my data.  Either the mutants do not cause a change in rate of linker proteolysis, or 
the difference is marginal in the rates of proteolysis.  This is similar to the marginal increases in 
proteolysis seen when stimulating the protein with ADP during proteolysis (experiments by Mike 
Murphy, Theis lab).  A confounding variable is the fact that the 450tev mutant introduced 6 
amino acids into the linker region, and as suggested in Figure 2.6(b), the protease recognition site 
may not be quite as buried in the protein as desired.  If somehow the inserted amino acids make 
the linker loop out even slightly, we may get identical cleavage no matter what mutants are made 
at the interface.  Perhaps the mutated linker is actually easily accessible to cleavage by TEV 
protease.  Supporting this is the fact that 450tev already stimulates ATPase activity above the 
levels of the wildtype protein, which was not expected.  Perhaps the insertion of the 6 amino 
acids actually pushes Mfd-C and Mfd-N slightly apart, increasing ATPase activity to a substantial 
degree as well as making the cut site accessible to protease even in this still “closed” form.  
Therefore, a possible solution would be to restrict the linker to its normal size by deleting 6 amino 
acids from another spot in the linker.  This may reverse the effect by keeping the cut site of the 
linker in this buried region.   
The ATPase assays performed indicate some exciting and promising results pertaining to 
the cleavable mutants.  804D is a small point mutation in a large protein that has been shown to 
significantly perturb the functional characteristics of Mfd.  Though present in domain 6 of the 
protein (one of the motor domains), the 804D mutation is far away from the ATP binding and 
hydrolysis site of the protein, which is located on the backside of the protein between domains 5 
and 6 (see Figure 2.6).  Nevertheless, the mutant has a significant effect on ATPase activity.  The 
804D mutant has a higher basal activity than that of any of the full length mutants.  This indicates 
that a change has occurred in the protein to activate it.  There is not much further stimulation of 
ATP activity by removing the N-terminus of 804D upon cleavage compared to that seen in the 
450tev, indicating that the mutant affects ATPase activity through eliminating interactions with 
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Mfd-N and not just through interactions within the motor domains of Mfd-C (as proposed by the 
Savery lab, Smith et al 2007).  This data is clear support for our open conformation hypothesis. 
 
Biological Implications 
Studying Mfd activation is important in understanding the biological implications of 
maintaining control over such activation.  Mfd represents a self-inhibiting protein that appears to 
regulate activity through its interactions with other molecules.  My work was to study the 
pathway of interaction from a closed to an open state.   
 
 
 
Why inhibit motor activity?  Because Mfd has a regulated process of activation, it is able 
to achieve higher specificity in the recognition, binding, and removal of RNA Polymerase from a 
damaged DNA strand.  By only becoming fully functional upon binding to a stalled RNA 
Polymerase (Figure 5.1, top panel), Mfd avoids removal of DNA bound proteins other than 
Figure 5.1:  Overview of Mfd’s Role in TCR.  In summary, my 
work focused on step #1, where Mfd is activated upon binding to 
RNA Polymerase by switching into an open conformation.   
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stalled RNAP.  Support for this high regulation of activation includes the fact that Mfd-C 
(representing a highly activated version of Mfd) can only be expressed in a tightly controlled 
strain of cells (studies by Peng Gong, Theis lab).  Mfd-C also is destabilized, having a thermal 
melting temperature approximately 8 °C lower than the wildtype protein.  Mfd-C also degrades 
quickly over time, while Mfd-N is highly stable.  The mutations I made seem to make the full-
length protein less stable (stability: wtMfd>450tev>∆7>804D>Mfd-C) while at the same time 
causing activation of the protein.  
Hyperactive mutants can be useful tools in future studies on the coupling function of 
Mfd.  As discussed in Table 1, a hyperactive mutant with weak MfdC-MfdN interactions would 
be expected to have certain properties, including high ATPase activity (seen in the 804D mutant).  
A hyperactive mutant is expected to be toxic to the cells, and would be characterized by strong 
binding to partners of interaction such as UvrA.  Perhaps using hyperactive mutants in association 
with DNA or UvrA (or other interacting partners) could lead to crystallization and 
characterization of the open state of Mfd.  This form would be highly significant to the study of 
coupling factors in general.  The bacterial system and the Mfd protein serve as a useful model for 
human studies on transcription-coupled repair.  Information on how to regulate and activate repair 
processes in the cell is extremely valuable in studying disease phenotypes such as cancer in 
humans.  
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